Most preclinical protocols begin with 0.51mg administered orally once daily, observing effects over 714 days before adjusting
Common side effects include: Nausea (the most frequent side effect) Stomach pain or bloating Diarrhea or constipation Vomiting Heartburn or acid reflux Mitigating Side Effects: Side effects are typically most intense when you first start the medication or when the dose is increased
Without biomarker data, perceived benefits are subjective
[46] reported that the GLP-1 analog exenatide increased hepatic mitochondrial respiration in high-fat fed mice in various respiratory states, such as LEAK, OXPHOS, and ETS
While causality has not been definitively established, acute pancreatitis has been observed in clinical trials and post-marketing reports
BPC-157 was shown to modulate the NO pathway in a context-dependent manner, counteracting both NO synthase blockade (L-NAME) and NO excess (L-arginine)